A regional cohort study of the treatment of critically ill children with bronchiolitis

Journal of Asthma

Volumn 53, Issue 10, 2016, Pages 1006-1011

  Carroll, Christopher L ^a   Faustino, Edward Vincent S ^b   Pinto, Matthew G ^c   Sala, Kathleen A ^a   Canarie, Michael F ^b   Li, Simon ^c   Giuliano, John S ^b   the Northeast Pediatric Critical Care Research Consortium, ^d  

^a Division of Pediatric Infectious Diseases   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WESTCHESTER MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

critical care; intensive care unit; pediatrics; respiratory failure; Respiratory syncytial virus

Indexed keywords

CORTICOSTEROID; SALBUTAMOL; SODIUM CHLORIDE; BRONCHODILATING AGENT;

ARTICLE; ARTIFICIAL VENTILATION; BREATHING EXERCISE; BRONCHIOLITIS; CHILDHOOD DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CRITICALLY ILL PATIENT; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY RISK; NASAL CANNULA; PEDIATRIC INTENSIVE CARE UNIT; RESPIRATORY TRACT INTUBATION; RETROSPECTIVE STUDY; UNITED STATES; CRITICAL ILLNESS; HOSPITAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

ALBUTEROL; BRONCHIOLITIS; BRONCHODILATOR AGENTS; CRITICAL ILLNESS; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; NEW ENGLAND; RESPIRATION, ARTIFICIAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 84979688293     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770903.2016.1180697     Document Type: Article

References (31)

1. J.J.Zorc, C.B.Hall. Bronchiolitis:Recent evidence on diagnosis and management. Pediatrics 2010;125:342–349.
2. S.Schuh. Update on management of bronchiolitis. Curr Opin Pediatr 2011;23:110–114.
3. F.D.Petruzella, M.H.Gorelick. Current therapies in bronchiolitis. Pediatr Emerg Care 2010;26:302–311.
4. S.L.Ralston, A.S.Lieberthal, H.C.Meissner, Alverson BK, Baley JE, Gadomski AM, et al. American Academy of Pediatrics. Clinical practice guideline:the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014;134:e1474–1502.
5. C.Wainwright. Acute viral bronchiolitis in children—a very common condition with few therapeutic options. Pediat Respir Rev 2010;11:39–45.
6. D.K.Shay, R.C.Holman, R.D.Newman, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 1999;282:1440–1446.
7. K.Hasegawa, Y.Tsugawa, D.F.M.Brown, Mansbach JM, Camargo CA Jr. Trends in bronchiolitis hospitalizations in the United States, 2000–2009. Pediatrics 2013;132:28–36.
8. A.A.El Kohly, N.A.Mostafa, S.A.El-Sherbini, Ali AA, Ismail RI, Magdy RI, et al. Morbidity and outcome of severe respiratory syncytial virus infection. Pediat Inter 2013;55:283–288.
9. D.Damore, J.M.Mansbach, S.Clark, Ramundo M, Camargo CA Jr. Prospective multicenter bronchiolitis study:predicting intensive care unit admissions. Acad Emerg Med 2008;15:887–894.
10. H.O.Skjerven, J.O.G.Hunderi, S.K.Brugmann-Pieper, Brun AC, Engen H, Eskedal L, et al. Racemic adrenaline and inhalation strategies in acute bronchiolitis. New England Journal of Medicine 2013;386:2286–2293.
11. L.Hartling, R.M.Fernandes, L.Bialy, Milne A, Johnson D, Plint A, et al. Steroids and bronchodilators for acute bronchiolitis in the first two years of life:systematic review and meta-analysis. Br Med J 2011;342:d1714.
12. A.M.Gadomski, A.L.Bhasale. Bronchodilators for bronchiolitis. Cochrane Database of System Rev 2006;3:CD001266.
13. L.Hartling, N.Wiebe, K.Russell, Patel H, Klassen TP. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediat Adolesc Med 2003;157:957–964.
14. R.M.Fernandes, L.M.Bialy, B.Vandermeer, Tjosvold L, Plint AC, Patel H, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database System Rev 2013;6:CD004878.
15. H.B.Panitch. Bronchiolitis in infants. Curr Opin Pediatr 2001; 13:256–260.
16. P.Flores, A.L.Mendes, A.S.Neto. A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants. Pediat Pulmonol 2016;51:418–425. doi:10.1002/ppul.23306
17. M.L.Everard, D.Hind, K.Ugonna, Freeman J, Bradburn M, Dixon S, et al. Saline in acute bronchiolitis RCT and economic evaluation:hypertonic saline in acute bronchiolitis – randomized controlled trial and systematic review. Health Technol Assess 2015;19:1–130.
18. T.A.Florin, T.Byczkowski, R.M.Ruddy, Zorc JJ, Test M, Shah SS. Utilization of nebulized 3% saline in infants hospitalized with bronchiolitis. J Pediat 2015;166:1168–1174.
19. D.F.Willson, S.D.Horn, O.Hendley, Smout R, Gassaway J. Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. Pediatrics 2001;108:851–855.
20. L.W.Johnson, J.Robles, A.Hudgins, Osburn S, Martin D, Thompson A. Management of bronchiolitis in the emergency department:impact of evidence-based guidelines? Pediatrics 2013;131:S103–S109.
21. C.P.Landrigan, P.H.Conway, E.R.Stucky, Chiang VW, Ottolini MC. Variation in pediatric hospitalists' use of proven and unproven therapies:a study from the Pediatric Research in Inpatient Settings (PRIS) network. J Hosp Med 2008;3:292–298.
22. J.Barben, C.E.Kuehni, D.Trachsel, Hammer J. Management of acute bronchiolitis:can evidence based guidelines alter clinical practice? Thorax 2008;63:1103–1109.
23. C.F.Barben J. Robertson, P.J.Robinson. Implementation of evidence-based management of acute bronchiolitis. J Paediat Child Health 2000;36:491–497.
24. J.L.Kimpen, U.B.Schaad. Treatment of respiratory syncytial virus bronchiolitis:1995 poll of members of the European Society for Paediatric Infectious Diseases. Pediat Infect Dis J 1997;16:479–481.
25. A.Slater, F.Shann, G.Pearson, for the PIM Study Group. PIM 2:a revised version of the paediatric index of mortality. Int Care Med 2003;29:278–285.
26. T.Lang. Documenting research in scientific articles:guidelines for authors. Chest 2007;131:628–632.
27. C.McKiernan, L.C.Chua, P.F.Visintainer, H.Allen. High flow nasal cannulae therapy in infants with bronchiolitis. J Pediatr 2010; 156:634–638.
28. A.Schibler, T.M.Pham, K.R.Dunster, Foster K, Barlow A, Gibbons K, et al. Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Int Care Med 2011;37:847–852.
29. S.L.Ralston, M.D.Garber, E.Rice-Conboy, Mussman GM, Shadman KA, Walley SC, et al. A multicenter collaborative to reduce unnecessary care in inpatient bronchiolitis. Pediatrics 2016;137:1–9.
30. P.A.Ross, C.J.L.Newth, C.A.C.Hugen, Maher JK, Deakers TW. Increase in oxygen consumption after albuterol inhalation in ventilated infants and children. PCCM 2014;15:e389–e392.
31. B.Oberwaldner. Physiotherapy for airway clearance in paediatrics. Eur Respir J 2000;15:196–204.